A novel aspochalasin with HIV-1 integrase inhibitory activity from Aspergillus flavipes

被引：44
作者：
Rochfort, S
Ford, J
Ovenden, S
Wan, SS
George, S
Wildman, H
Tait, RM
Meurer-Grimes, B
Cox, S
Coates, J
Rhodes, D
机构：
[1] Cerylid Biosci, Richmond, Vic 3121, Australia
[2] Amrad Corp Ltd, Richmond, Vic 3121, Australia
来源：
JOURNAL OF ANTIBIOTICS | 2005年 / 58卷 / 04期
关键词：
Aspergillus flavipes; aspochalasin; HIV integrase; cytochalasins;
D O I：
10.1038/ja.2005.34
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
sA novel aspochalasin, aspochalasin L (1), was isolated from the fermentation broth of a soil-derived fungal culture identified as Aspergillus flavipes (Deuteromycota). Structure elucidation of 1 was accomplished by detailed spectroscopic data analyses and by comparison with related cytochalasins. Aspochalasin L demonstrated activity against HIV integrase with an IC50 of 71.7 mu M.
引用
收藏
页码：279 / 283
页数：5
相关论文
共 45 条
  • [31] Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies
    Ma, XH
    Zhang, XY
    Tan, JJ
    Chen, WZ
    Wang, CX
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (07) : 950 - 958
  • [32] Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors
    Sharma, Horrick
    Patil, Shivaputra
    Sanchez, Tino W.
    Neamati, Nouri
    Schinazi, Raymond F.
    Buolamwini, John K.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (06) : 2030 - 2045
  • [33] Isolation and Identification of FR198248, a Hydroxylated 1,3-Dihydroisobenzofuran, from Aspergillus flavipes as an Inhibitor of Peptide Deformylase
    Kwon, Yun-Ju
    Zheng, Chang-Ji
    Kim, Won-Gon
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (02) : 390 - 393
  • [34] Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1
    Meadows, D. Christopher
    Sanchez, Tino
    Neamati, Nouri
    North, Thomas W.
    Gervay-Hague, Jacquelyn
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) : 1127 - 1137
  • [35] Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK
    Tanis, Steven P.
    Plewe, Michael B.
    Johnson, Ted W.
    Butler, Scott L.
    Dalvie, Deepak
    DeLisle, Dorothy
    Dress, Klaus R.
    Hu, Qiyue
    Huang, Buwen
    Kuehler, Jon E.
    Kuki, Atsuo
    Liu, Wen
    Peng, Qinghai
    Smith, Graham L.
    Solowiej, Jim
    Tran, Khanh T.
    Wang, Hai
    Yang, Anle
    Yin, Chunfeng
    Yu, Xiaoming
    Zhang, Junhu
    Zhu, Huichun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7429 - 7434
  • [36] Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda
    McCluskey, Suzanne M.
    Kamelian, Kimia
    Musinguzi, Nicholas
    Kigozi, Simone
    Boum, Yap
    Bwana, Mwebesa B.
    Muzoora, Conrad
    Brumme, Zabrina L.
    Carrington, Mary
    Carlson, Jonathan
    Foley, Brian
    Hunt, Peter W.
    Martin, Jeffrey N.
    Bangsberg, David R.
    Harrigan, P. Richard
    Siedner, Mark J.
    Haberer, Jessica E.
    Lee, Guinevere Q.
    AIDS, 2021, 35 (07) : 1083 - 1089
  • [37] 10-hydroxy-7,8-dihydropyrazino[1′,2′:1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones:: Potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants
    Wiscount, Catherine M.
    Williams, Peter D.
    Tran, Lekhanh O.
    Embrey, Mark W.
    Fisher, Thorsten E.
    Sherman, Vanessa
    Homnick, Carl F.
    Staas, D. Donnette
    Lyle, Terry A.
    Wai, John S.
    Vacca, Joseph P.
    Wang, ZiQiang
    Felock, Peter J.
    Stillmock, Kara A.
    Witmer, Marc V.
    Miller, Michael D.
    Hazuda, Daria J.
    Day, Alysha M.
    Gabryelski, Lori J.
    Ecto, Linda T.
    Schleif, William A.
    DiStefano, Daniel J.
    Kochansky, Christopher J.
    Anari, M. Reza
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4581 - 4583
  • [38] Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
    Thibault Mesplède
    Peter K Quashie
    Nathan Osman
    Yingshan Han
    Diane N Singhroy
    Yolanda Lie
    Christos J Petropoulos
    Wei Huang
    Mark A Wainberg
    Retrovirology, 10
  • [39] Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
    Mesplede, Thibault
    Quashie, Peter K.
    Osman, Nathan
    Han, Yingshan
    Singhroy, Diane N.
    Lie, Yolanda
    Petropoulos, Christos J.
    Huang, Wei
    Wainberg, Mark A.
    RETROVIROLOGY, 2013, 10
  • [40] Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase
    Sun, Yixing
    Xu, Weisi
    Fan, Ningning
    Sun, Xuefeng
    Ning, Xianling
    Ma, Liying
    Liu, Junyi
    Wang, Xiaowei
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (03) : 1076 - 1084
12345